Clinical Trials Logo

Thoracic Neoplasms clinical trials

View clinical trials related to Thoracic Neoplasms.

Filter by:

NCT ID: NCT04209868 Recruiting - Anesthesia, Local Clinical Trials

Preoperative Paravertebral Block in Cancer Surgery of the Lung

ParaSOL
Start date: February 1, 2019
Phase: Phase 2/Phase 3
Study type: Interventional

The investigators aim to determine whether ultrasound-guided preemptive paravertebral blockade (PVB) local anaesthetic (pre-PVB LA), administered in addition to the post-operative PVB (post-PVB) local anaesthetic (LA) infusion, reduces acute postoperative pain, opioid requirement, chronic pain, and improves surgical recovery, in thoracoscopic surgery for lung cancer.

NCT ID: NCT04133337 Not yet recruiting - Neoplasms Clinical Trials

Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC

Start date: November 1, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

The aim of this study was to investigate the safety and efficacy of SHR-1210 in combination with the anti-vascular survival target drug apatinib in patients with resectable NSCLC, and to provide new treatment options for neoadjuvant therapy in patients with the period IB-IIIA NSCLC.

NCT ID: NCT04072393 Recruiting - Breast Cancer Clinical Trials

Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers

Start date: January 15, 2021
Phase: N/A
Study type: Interventional

Other than optimizing medical management of cardiac risk factors, and reducing radiotherapy (RT) dose to the heart, there currently exist no interventions to mitigate or reverse the adverse cardiac effects of RT. Aerobic exercise has been demonstrated to improve patient quality of life, cardiac outcomes, and cardiorespiratory fitness in patients with cancer receiving cardiotoxic systemic therapies, but the effects of aerobic exercise on patients at high risk for radiation induced heart disease (RIHD) is unknown. In addition, home-based cardiac rehabilitation has not been tested in patients with thoracic cancers.

NCT ID: NCT03903991 Completed - Anesthesia Clinical Trials

Evaluation of the Reliability of Oesophageal Temperature in THOracic Surgery

ThoTem
Start date: July 18, 2019
Phase:
Study type: Observational

Controlling hypothermia is essential in anesthesia to limit postoperative complications. Temperature monitoring is therefore essential. However, the reliability of esophageal temperature during open chest lung surgery is discussed and not accurately assessed in the literature.

NCT ID: NCT03890640 Completed - Thoracic Neoplasm Clinical Trials

Ultrasound-assisted Thoracic Epidural Catheter Insertion

Start date: July 4, 2019
Phase: N/A
Study type: Interventional

The aim of the present study is to access the success rate of ultrasound-guided thoracic epidural catheter insertion, using fluoroscopy.

NCT ID: NCT03868579 Active, not recruiting - Malignant Neoplasm Clinical Trials

Rapid On Site Evaluation of Pleural Touch Preparations in Diagnosing Malignant Pleural Effusion in Patients Undergoing Pleuroscopy

Start date: January 10, 2018
Phase: N/A
Study type: Interventional

This trial studies how well rapid on site evaluation of pleural touch preparations works in diagnosing cancerous fluid in between the linings of the lungs (malignant pleural effusion) in patients undergoing a pleuroscopy. A type of laboratory testing called rapid on site evaluation of pleural touch preparations that uses pleural biopsy tissue samples collected during an already-scheduled pleuroscopy may be able to diagnose malignant pleural effusion.

NCT ID: NCT03804307 Recruiting - Palliative Care Clinical Trials

Short Course Radiation Therapy in Palliative Treatment of Thoracic Cancer

Start date: November 8, 2017
Phase: N/A
Study type: Interventional

Aim of the study is to assess efficacy of a short course radiation treatment in patients with symptomatic thoracic malignant lesions

NCT ID: NCT03583086 Active, not recruiting - Clinical trials for Non-small Cell Lung Cancer

Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors

Start date: July 10, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

This is a two-agent, open-label, non-randomized, Phase 1/2 dose escalation and dose expansion study of combinatorial oral vorolanib plus infusional nivolumab in patients with Non-Small Cell Lung Cancer naïve to checkpoint inhibitor therapy, Non-Small Cell Lung Cancer who have progressed on checkpoint inhibitor therapy, Small Cell Lung Cancer ( who have progressed on platinum-based chemotherapy, and thymic carcinoma.

NCT ID: NCT03521986 Recruiting - Thoracic Surgery Clinical Trials

Pain and Quality of Life After Mediastinal Tumor Resection by Subxiphoid and Intercostal VATS

Start date: April 4, 2018
Phase: Phase 3
Study type: Interventional

Thoracoscopic assisted mediastinal thymectomy is currently one of the most commonly used surgical methods, but there are some deficiencies.Minimally invasive surgery through the subxiphoid approach can achieve a good surgical field of vision. (1) The surgical field is fully exposed. (2) damage to intercostal nerves can be avoided.(3) Operation time, intraoperative blood loss, postoperative Extubation time is similar to VATS. But there is still lack of evidence. In this study, 50 patients undergoing subxiphoid uniportal VATS and 50 patients undergoing intercostal uniportal VATS were included to evaluate the post-operative pain and quality of life after surgery.

NCT ID: NCT03477162 Terminated - Thoracic Neoplasm Clinical Trials

Metformin Pharmacology in Human Cancers: A Proof of Principle Study

Start date: May 15, 2018
Phase: Early Phase 1
Study type: Interventional

This is a presurgical (proof of principle, window of opportunity) study in patients with surgically resectable thoracic tumors to determine steady-state tissue and plasma concentrations of metformin.